258 related articles for article (PubMed ID: 33633147)
1. Reappraisal of the incidence, various types and risk factors of malignancies in patients with dermatomyositis and polymyositis in Taiwan.
Hsu JL; Liao MF; Chu CC; Kuo HC; Lyu RK; Chang HS; Chen CM; Wu YR; Chang KH; Weng YC; Chang CW; Chiang HI; Cheng CK; Lee PW; Huang CC; Ro LS
Sci Rep; 2021 Feb; 11(1):4545. PubMed ID: 33633147
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of venous thromboembolism in patients with dermatomyositis/polymyositis: a nationwide cohort study.
Chung WS; Lin CL; Sung FC; Lu CC; Kao CH
Thromb Res; 2014 Sep; 134(3):622-6. PubMed ID: 25034321
[TBL] [Abstract][Full Text] [Related]
3. Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan.
Chen YJ; Wu CY; Huang YL; Wang CB; Shen JL; Chang YT
Arthritis Res Ther; 2010; 12(2):R70. PubMed ID: 20398365
[TBL] [Abstract][Full Text] [Related]
4. Routine vs extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients.
Sparsa A; Liozon E; Herrmann F; Ly K; Lebrun V; Soria P; Loustaud-Ratti V; Bouyssou-Gauthier ML; Boulinguez S; Bédane C; Jauberteau MO; Vidal E; Bonnetblanc JM
Arch Dermatol; 2002 Jul; 138(7):885-90. PubMed ID: 12071815
[TBL] [Abstract][Full Text] [Related]
5. Risk of Malignancy in Dermatomyositis and Polymyositis.
Qiang JK; Kim WB; Baibergenova A; Alhusayen R
J Cutan Med Surg; 2017; 21(2):131-136. PubMed ID: 27534779
[TBL] [Abstract][Full Text] [Related]
6. Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis.
Azuma K; Yamada H; Ohkubo M; Yamasaki Y; Yamasaki M; Mizushima M; Ozaki S
Mod Rheumatol; 2011 Apr; 21(2):178-83. PubMed ID: 20922453
[TBL] [Abstract][Full Text] [Related]
7. Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study.
Chen YJ; Wu CY; Shen JL
Br J Dermatol; 2001 Apr; 144(4):825-31. PubMed ID: 11298544
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and prognosis of polymyositis and dermatomyositis associated with malignancy: a 25-year retrospective study.
Motomura K; Yamashita H; Yamada S; Takahashi Y; Kaneko H
Rheumatol Int; 2019 Oct; 39(10):1733-1739. PubMed ID: 31444556
[TBL] [Abstract][Full Text] [Related]
9. Malignancy in dermatomyositis and polymyositis: analysis of 192 patients.
Fang YF; Wu YJ; Kuo CF; Luo SF; Yu KH
Clin Rheumatol; 2016 Aug; 35(8):1977-1984. PubMed ID: 27210465
[TBL] [Abstract][Full Text] [Related]
10. Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study.
Kuo CF; See LC; Yu KH; Chou IJ; Chang HC; Chiou MJ; Luo SF
Br J Dermatol; 2011 Dec; 165(6):1273-9. PubMed ID: 21895620
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic inflammatory myopathy associated with malignancy: a retrospective cohort of 151 Korean patients with dermatomyositis and polymyositis.
So MW; Koo BS; Kim YG; Lee CK; Yoo B
J Rheumatol; 2011 Nov; 38(11):2432-5. PubMed ID: 21844145
[TBL] [Abstract][Full Text] [Related]
12. Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study.
Huang YL; Chen YJ; Lin MW; Wu CY; Liu PC; Chen TJ; Chen YC; Jih JS; Chen CC; Lee DD; Chang YT; Wang WJ; Liu HN
Br J Dermatol; 2009 Oct; 161(4):854-60. PubMed ID: 19558555
[TBL] [Abstract][Full Text] [Related]
13. Increased osteoporosis risk in dermatomyositis or polymyositis independent of the treatments: a population-based cohort study with propensity score.
Lee CW; Muo CH; Liang JA; Sung FC; Hsu CY; Kao CH
Endocrine; 2016 Apr; 52(1):86-92. PubMed ID: 26429781
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of serum markers for the development of interstitial lung disease in patients with polymyositis and dermatomyositis: a comparative and prospective study.
Chen F; Lu X; Shu X; Peng Q; Tian X; Wang G
Intern Med J; 2015 Jun; 45(6):641-7. PubMed ID: 25827843
[TBL] [Abstract][Full Text] [Related]
15. Epidemiologic analysis of the clinical features of Japanese patients with polymyositis and dermatomyositis.
Tomimitsu H; Ohta A; Nagai M; Nishina M; Ishihara S; Kohsaka H
Mod Rheumatol; 2016; 26(3):398-402. PubMed ID: 26375202
[TBL] [Abstract][Full Text] [Related]
16. Malignancies in Korean patients with inflammatory myopathy.
Lee SW; Jung SY; Park MC; Park YB; Lee SK
Yonsei Med J; 2006 Aug; 47(4):519-23. PubMed ID: 16941742
[TBL] [Abstract][Full Text] [Related]
17. Traditional cardiovascular risk factors and coronary artery calcification in adults with polymyositis and dermatomyositis: a Danish multicenter study.
Diederichsen LP; Diederichsen AC; Simonsen JA; Junker P; Søndergaard K; Lundberg IE; Tvede N; Gerke O; Christensen AF; Dreyer L; Petersen H; Ejstrup L; Kay SD; Jacobsen S
Arthritis Care Res (Hoboken); 2015 May; 67(6):848-54. PubMed ID: 25418360
[TBL] [Abstract][Full Text] [Related]
18. Association between clinical phenotypes of dermatomyositis and polymyositis with myositis-specific antibodies and overlap systemic autoimmune diseases.
Chiang HL; Tung CH; Huang KY; Hsu BB; Wu CH; Hsu CW; Lu MC; Lai NS
Medicine (Baltimore); 2021 Sep; 100(37):e27230. PubMed ID: 34664863
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort.
Dobloug C; Garen T; Bitter H; Stjärne J; Stenseth G; Grøvle L; Sem M; Gran JT; Molberg Ø
Ann Rheum Dis; 2015 Aug; 74(8):1551-6. PubMed ID: 24695011
[TBL] [Abstract][Full Text] [Related]
20. Hematological malignancy associated with polymyositis and dermatomyositis.
Marie I; Guillevin L; Menard JF; Hatron PY; Cherin P; Amoura Z; Cacoub P; Bachelez H; Buzyn A; Le Roux G; Ziza JM; Brice P; Munck JN; Sarrot-Reynauld F; Piette JC; Larroche C
Autoimmun Rev; 2012 Jul; 11(9):615-20. PubMed ID: 22079677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
